Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital voice analysis as a biomarker of acromegaly.
Vouzouneraki K, Nylén F, Holmberg J, Olsson T, Berinder K, Höybye C, Petersson M, Bensing S, Åkerman AK, Borg H, Ekman B, Robért J, Engström BE, Ragnarsson O, Burman P, Dahlqvist P. Vouzouneraki K, et al. Among authors: ragnarsson o. J Clin Endocrinol Metab. 2024 Oct 4:dgae689. doi: 10.1210/clinem/dgae689. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39363748
[Obesity isn't always obesity: Cushing's disease - case report].
Bjornsson AH, Hardarson TO, Olafsson IH, Ragnarsson O, Sigurjonsdottir HA. Bjornsson AH, et al. Among authors: ragnarsson o. Laeknabladid. 2020 Oct;106(10):460-463. doi: 10.17992/lbl.2020.10.601. Laeknabladid. 2020. PMID: 32991308 Free article. Icelandic.
Psychiatric and neurocognitive consequences of endogenous hypercortisolism.
Piasecka M, Papakokkinou E, Valassi E, Santos A, Webb SM, de Vries F, Pereira AM, Ragnarsson O. Piasecka M, et al. Among authors: ragnarsson o. J Intern Med. 2020 Aug;288(2):168-182. doi: 10.1111/joim.13056. Epub 2020 Apr 29. J Intern Med. 2020. PMID: 32181937 Free article. Review.
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennernäs H, Skrtic S. Johannsson G, et al. Among authors: ragnarsson o. J Clin Endocrinol Metab. 2012 Feb;97(2):473-81. doi: 10.1210/jc.2011-1926. Epub 2011 Nov 23. J Clin Endocrinol Metab. 2012. PMID: 22112807 Clinical Trial.
Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
Nilsson AG, Marelli C, Fitts D, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Lennernäs H, Skrtic S, Johannsson G. Nilsson AG, et al. Among authors: ragnarsson o. Eur J Endocrinol. 2014 Sep;171(3):369-77. doi: 10.1530/EJE-14-0327. Epub 2014 Jun 18. Eur J Endocrinol. 2014. PMID: 24944332 Free PMC article. Clinical Trial.
142 results